ESR1 and cancer: Moreover, O-GlcNAcylation participates in the regulation of the epigenome and transcription factors activity (MYC, p53, NFκΒ, β-catenin, FOXM1, estrogen receptor (1) as well as in reprogramming of the metabolic network of cancer cells to promote tumor growth.